REQ-23618-50305
3 vaccinations
3 coded responses
25 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 085 / NJ
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-07
- 2021-04-14
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
-
2021-05-12
Survey response — day 14, dose 2MedDRA: Dyspnoea, Headache — Feeling: FairFree text: Headache, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
-
2021-07-28
Survey response — 3 months, dose 2MedDRA: Cough, Gastrointestinal disorder — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough for 4 weeks, gi issuesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-28
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-02
- 2021-10-27
-
2022-02-04
Dose 3 — Pfizer-BioNTech
- 2022-04-28
- 2022-05-06
-
2022-08-07
Survey response — 6 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): Regular prenatal careMedDRA releases: 2024-11 · check-in free text available
-
2022-08-07
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-08-08
- 2022-08-08
- 2023-02-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2022-02-04 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — day 14, dose 2
Symptoms: Headache, shortness of breath
Release 9 — 3 months, dose 2
Symptoms: Cough for 4 weeks, gi issues
Release 12 — 6 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release